Outpace Bio logoOutpace Bio logo

Clinical Scientist at Outpace Bio | Seattle

Outpace BioSeattle, WA
On-site Full-time $144K/yr - $144K/yr

Clicking Apply Now takes you to AutoApply where you can tailor your resume and apply.


Experience Level

Experience

Qualifications

Qualifications:1. PhD in Immunology, Cell Biology, or a related field.2. Proven experience in cellular therapy or protein engineering.3. Strong analytical skills and proficiency in data analysis software.4. Excellent communication and teamwork abilities.5. A passion for innovation and a commitment to advancing therapeutic solutions.

About the job

About Outpace Bio
Outpace Bio is at the forefront of revolutionizing cell therapy for solid tumors, leveraging cutting-edge AI-driven protein design. Our mission focuses on programming immune cells to enhance their functionality within patients, addressing critical challenges such as inadequate tumor access, limited cell survival, antigen escape, and dose-related toxicity. By developing and integrating modular, plug-and-play technology assets, we are creating cell therapies that promise unprecedented efficacy, fundamentally transforming the interaction of engineered T cells with cancer and the immune system to achieve life-altering results. Our diverse team of scientists, engineers, coders, and cell therapy developers operates at the vanguard of computational protein design, synthetic biology, and immunology. Together, we are reimagining cellular functions to unlock new therapeutic avenues.

Our Commitment to Diversity
We recognize that high-performing teams thrive on diverse backgrounds and experiences. At Outpace Bio, we are dedicated to fostering an inclusive culture for all employees. We encourage applications from individuals who feel they could contribute to our mission of curing diseases by pushing the boundaries of biology, even if they do not meet every qualification listed.

Our Momentum
In August 2024, Outpace Bio successfully raised an oversubscribed $144 million Series B financing round, led by RA Capital Management and backed by a distinguished group of life science investors. This funding will accelerate our pipeline of programmed T cell therapies, including our lead candidate OPB-101, a mesothelin-specific chimeric antigen receptor (CAR) T cell enhanced by our proprietary OUTSMART™, OUTLAST™, OUTSPACER™, and OUTSAFE™ technologies. OPB-101 is on track for IND clearance and first dosing in 2025 for patients with advanced platinum-resistant ovarian cancers. The Series B investment will also enable us to expand our pipeline, allowing the development of additional transformational therapies.

About Outpace Bio

Outpace Bio is a pioneering biotechnology company dedicated to developing AI-driven cell therapies for solid tumors. With a diverse team and a commitment to respect and inclusion, we strive to transform cancer treatment through groundbreaking innovations in immunology and synthetic biology.

Similar jobs

Browse all companies, explore by city & role, or SEO search pages. View directory listings: all jobs, search results, location & role pages.

Tailoring 0 resumes

We'll move completed jobs to Ready to Apply automatically.